Michiharu Sugawara

Title: Michiharu Sugawara: Innovator in Pharmaceutical Compounds

Introduction

Michiharu Sugawara is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic potential. With a total of 3 patents to his name, Sugawara's work is recognized for its impact on medical science.

Latest Patents

One of Sugawara's latest patents is for a novel pyrazinoxide compound, designated as NF-1616-904. This compound is prepared by hydrolyzing an intermediate compound, NF-1616-902, which is isolated from a culture broth of a microorganism belonging to the genus Thielavia. The pyrazinoxide compound NF-1616-904 exhibits biological and pharmacological activities, making it a valuable agent for preventing and treating diseases caused by superoxide radicals (O.sub.2.sup.-) and nephritis.

Career Highlights

Sugawara is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on developing compounds that can address significant health challenges.

Collaborations

Throughout his career, Sugawara has collaborated with esteemed colleagues, including Tsutomu Nishida and Takashi Kamogashira. These partnerships have contributed to the advancement of his research and the successful development of new pharmaceutical agents.

Conclusion

In summary, Michiharu Sugawara is a distinguished inventor whose work in pharmaceutical compounds has the potential to make a significant impact on healthcare. His innovative contributions continue to advance the field and offer hope for effective treatments.